Enthusiasm vs. evidence for COVID-19 pharmacotherapies: what do we know and what have we learnt? - Joint with (ISCP)
Prevention of thromboembolism in COVID-19
#ESCCongress @escardio @ESC_Lavinia @Steph_Achenbach @susannaprice @mmamas1973 @fhussain73 @DrJennHaythe md
Recommendation for thrombophylaxis in COVID19
#ESCCongress @escardio @ESCardioNews @ESC_Lavinia @mmamas1973 @fhussain73 @susannaprice @JJcolemanMD @DrJennHaythe @PeterHotez @VirusesImmunity @bchTicTocDoc @AnastasiaSMihai
COVID-19 #myocarditis and myocardial injury: active participant or innocent bystander?
#ESCCongress
@escardio @DrJennHaythe @AnastasiaSMihai @CMichaelGibson @mmamas1973 @EricTopol @ErinMichos @DBelardoMD @fhussain73 @VirusesImmunity @fhussain73 @pabeda1 @JGrapsa
From acute to chronic COVID
Microthrombi is major source of myocardial injury in #COVID19
#ESCCongress @escardio @ESC_Lavinia @ESC_Journals @ErinMichos @CVR_TomaszGuzik @ATVBCouncil @MKIttlesonMD @heartcuredoc @DrJennHaythe @ShelleyZieroth @MeralKayikcoglu @ProfKausikRay
How large impact of COVID19 pandemic on CVD and care
#ESCCongress @escardio
Anti-inflammatory treatment of COVID-19 patients: which drugs and which patients?
#ESCCongress @Steph_Achenbach @escardio @ESC_Lavinia @ESC_Journals @mmamas1973 @VirusesImmunity @PeterHotez @EricTopol @ErinMichos @DrJennHaythe @DrMarthaGulati @fhussain73 @pabeda1 @BiykemB
What is needed in relation to the evidence on Immunomodulatory Rx for COVID19 ?
What are ongoings ?
#ESCCongress @escardio @ESC_Journals @DLBHATTMD @VietHeartPA @ATVBCouncil @CVR_TomaszGuzik @mmamas1973 @JGrapsa @PeterHotez @VirusesImmunity @VDelgadoGarcia
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.